Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04623957
Other study ID # PANSATORI-001
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 30, 2020
Est. completion date November 30, 2021

Study information

Verified date November 2020
Source Pansatori GmbH
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main objective of this clinical trial is to evaluate the effectiveness and safety of the medical product ForgTin with regard to the impairment and change in the sensation of tinnitus (volume, frequency, psychological stress).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 35
Est. completion date November 30, 2021
Est. primary completion date September 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Male and female patients (aged > 18 years) - Subjective tinnitus in one or both ears with intermittent or continuous symptoms with a duration of > 6 months - Tinnitus of Grade II, III or IV according to Mini-Tinnitus-Questionnaire (Mini-TF12): - Grade II (score of 8-12): moderately distressed - Grade III (score of 13-18): severely distressed - Grade III (score of 19-24): most severely distressed - If a drug therapy with psychoactive substances (e.g. antidepressants, anticonvulsants) exists at the beginning of the therapeutic intervention, it must have been stable for at least 30 days. The therapy should remain constant during the duration of the study, but a necessary change is not an exclusion criterion. Any change in medication is documented in the CRF. - Provides written informed consent Exclusion Criteria: - Vestibular schwannoma (acoustic neuroma) - Objective tinnitus - Any other tinnitus-related treatment - Ménière's Disease - Acute infections of the hearing system (acute otitis media, otitis externa, acute sinusitis) - Acute infections (acute otitis media, otitis externa, acute sinusitis) - Hearing aids or Cochlear Implants (CI) - Any current treatment with anticonvulsants, cortisone, tricyclic antidepressants - Other lesions (glomus tumors, meningiomas, adenomas, vascular lesions or neuro-vascular conflicts) detected by clinical assessment - Serious, concomitant disorder, including major depression, anxiety - Any condition that, in the judgment of the investigator, might prevent safe participation in the study or interfere with study objectives - Inability to comply with the protocol requirements

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ForgTin©
The device is clamped behind the ear via two connected temple parts that pressed together around the connecting axis until an individual perfect wearing comfort is achieved. The pressure is adjusted so that the wearing of ForgTin© is barely noticed at all and may be changed at any time. The aim is a slight pressure stimulation of clearly defined points behind the ear - thus wearing ForgTin© leads to a minimization of individual tinnitus noises.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Pansatori GmbH Competence Center for Medical Devices GmbH

Outcome

Type Measure Description Time frame Safety issue
Primary Tinnitus Handicap Inventory Tinnitus Impairment as assessed by the Tinnitus Handicap Inventory (THI) Change of the Tinnitus Handicap Inventory assessed at Day 0, Month 3, Month 4, Month 7
See also
  Status Clinical Trial Phase
Recruiting NCT04987502 - Virtual Reality and Subjective Tinnitus N/A
Completed NCT04281953 - Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors
Recruiting NCT04404439 - Treatment of Tinnitus With Migraine Medications Phase 4
Completed NCT03782220 - Effects of Kinesio Taping in Patients With Somatosensory Tinnitus N/A
Completed NCT05711641 - Action of Intra-auricular Topical Lidocaine on Tinnitus N/A
Completed NCT03711630 - Impact of Meditation on Bothersome Tinnitus N/A
Completed NCT05591144 - Short-term Oral Prednisone for Acute Subjective Tinnitus N/A
Completed NCT04565132 - HD-tDCS as a Treatment for Chronic Tinnitus N/A
Completed NCT02315508 - Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo Phase 2
Active, not recruiting NCT03888521 - Evaluating the GN ReSound Relief App Using task-and Rest-based fMRI N/A
Not yet recruiting NCT05507372 - Treatment for Post Acute COVID-19 Syndrome N/A
Recruiting NCT05198973 - Bumblebee Breath Effect on Tinnitus in Older Patients N/A
Recruiting NCT05964725 - The Study on Effect and Neural Network Mechanism of Transcranial Direct Current Stimulation for Sudden Deafness With Tinnitus N/A
Not yet recruiting NCT05417711 - Efficacy of Transcutaneous Vagus Nerve Stimulation Paired With Tailor-Made Notched Music Therapy Versus Tailor-made Notched Music Training for Chronic Subjective Tinnitus N/A
Recruiting NCT04162405 - Tinnitus in Patients With and Without Sensorineural Hearing Loss
Completed NCT03716544 - Efficacy of Amplification With Hearing Aids for Tinnitus Relief N/A
Completed NCT03638986 - Comparison of the Two Validated German Versions of the "Tinnitus Functional Index" for Switzerland and for Germany
Completed NCT04127708 - Tinnitus and Acupuncture N/A
Not yet recruiting NCT06433895 - Efficacy of Manual Therapy in the Treatment of Somatic Tinnitus N/A
Enrolling by invitation NCT04382807 - Internet-delivered Group Counseling for Chronic Tinnitus